| Literature DB >> 36046441 |
B Rajasekar1, P Nirmala2, P Bhuvaneswari3, R Radhika4, S Asha5, K R Kavitha6, Semagn Shifere Belay7.
Abstract
Numerous traditional medical imaging methods, including computed tomography with X-rays, positron emission tomography (PET), and magnetic resonance imaging (MRI), are utilized frequently in medical settings to screen for illnesses, diagnose patients, and track the effectiveness of treatments. When examining bone protrusions, CT is preferred over MRI for scanning connective tissue. Although the picture quality of PET is inferior to that of CT and MR, it is outstanding for detecting the molecular markers and metabolic functions of illnesses. To give high-resolution structural pictures and improved ailment sensitivity and specificity within another image, multimodal data and substantial therapeutic influence on advanced diagnostics and therapeutics have been used. The goal was to evaluate the clinical significance of multimodal photoacoustic/ultrasound (PA/US) articular imaging scoring, a cutting-edge image technique that may show the microvessels and oxygen levels of rheumatoid arthritis-related inflamed joints (RA). The PA/US imaging technology analyzed seven tiny joints. The PA and power Doppler (PD) impulses were semiquantified using a 0-3 grading scale, and the averages of the PA and PD scores for the seven joints are computed. Three PA+SO2 types were found determined by the relative oxygen levels (SO2) measurements of the affected joints. Researchers evaluated the relationships between the disease activity ratings and the PA/US imaging ratings. The PA scores and medical ratings that reflect the extent of the pain have strong relationships with each other, as do the PA+SO2 combinations. PA may be clinically useful in assessing RA. Thus, the research evaluated the clinical symptoms of inflammatory arthritis using a multimodal photoacoustic image process.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36046441 PMCID: PMC9420593 DOI: 10.1155/2022/7358575
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Figure 1Different optoacoustic imaging molecule and tissues.
Figure 2Block diagram of PA/US system.
Figure 3Generation and detection based on signal.
Medical features of RA patients.
| Features | Average value |
|---|---|
| Age | 51.9 ± 12.4 |
| Erythrocyte sedimentation | 21.5 ± 26.3 |
| C-reactive protein | 12.4 ± 24.6 |
| Inflamed jt counts | 7.6 ± 8.1 |
| Tender jt counts | 7.3 ± 8.2 |
| Pain visual analog scale | 24.4 ± 3.13 |
| Patient global activity | 26.6 ± 30 |
| Evaluator global activity | 22.5 ± 26.6 |
| Infection rate in 28 joints (CRP) | 3.8 ± 2.2 |
| Infection rate in 28 joints (ESR) | 3.8 ± 1.1 |
| Simplified disease index | 21.2 ± 20.2 |
| Medical infection index | 19.5 ± 19 |
| PD sum of power | 2.9 ± 3.4 |
| PA sum of power | 4.6 ± 3.8 |
PD score and PA.
| Photoacoustic score | Power Doppler score | Overall | |||
|---|---|---|---|---|---|
| A | B | C | D | ||
| A | 148 | 0 | 0 | 0 | 148 |
| B | 22 | 5 | 0 | 0 | 27 |
| C | 6 | 3 | 11 | 0 | 20 |
| D | 0 | 3 | 5 | 14 | 22 |
| Overall | 176 | 11 | 16 | 14 | 217 |
RA infection and correlation coefficient of A-PD and B-PA.
| Correlation coefficient | 97% confidence interval | Probability rate | ||
|---|---|---|---|---|
| Erythrocyte sedimentation | A-PD sum | 0.212 | -0.155-0.527 | 0.255 |
| B-PA sum | 0.26 | -0.0993-0.567 | 0.263 | |
| C-reactive protein | A-PD sum | 0.433 | 0.0923-0.683 | 0.0152 |
| B-PA sum | 0.545 | 0.236-0.754 | 0.0017 | |
| Swollen joint count | A-PD sum | 0.700 | 0.454-0.847 | <0.0002 |
| B-PA sum | 0.793 | 0.505-0.97 | <0.0002 | |
| Tender joint count | A-PD sum | 0.720 | 0.485-0.858 | <0.0002 |
| B-PA sum | 0.802 | 0.621-0.802 | <0.0002 | |
| Paining visual analog scale | A-PD sum | 0.509 | 0.182-0.735 | 0.0032 |
| B-PA sum | 0.699 | 0.452-0.845 | <0.0002 | |
| Patient global activity | A-PD sum | 0.197 | -0.177-0.521 | 0.299 |
| B-PA sum | 0.483 | 0.148-0.719 | 0.0071 | |
| Evaluator global activity | A-PD sum | 0.422 | 0.0713-0.679 | 0.0205 |
| B-PA sum | 0.623 | 0.339-0.804 | 0.0023 | |
| Disease activity score in 28 joints (CRP) | A-PD sum | 0.652 | 0.386-0.818 | 0.0002 |
| B-PA sum | 0.755 | 0.547-0.876 | <0.0002 | |
| Disease activity score in 28 joints (ESR) | A-PD sum | 0.677 | 0.423-0.832 | <0.0002 |
| B-PA sum | 0.797 | 0.616-0.898 | <0.0002 | |
| Simplified disease activity index | A-PD sum | 0.717 | 0.485-0.855 | <0.0002 |
| B-PA sum | 0.837 | 0.685-0.919 | <0.0002 | |
| Clinical disease activity index | A-PD sum | 0.710 | 0.474-0.851 | <0.0002 |
| B-PA sum | 0.838 | 0.690-0.920 | <0.0002 |
Figure 4Image scoring fitting curve and scatter points.
PA+SO2 pattern of clinical scores.
| Pattern 1 ( | Pattern 2 ( | Pattern 3 ( |
|
| |
|---|---|---|---|---|---|
| Erythrocyte sedimentation rate | 13.9 ± 14.5 | 26.9 ± 32.1 | 26.6 ± 30.5 | 0.3307 | 0.607 |
| Simplified disease activity index | 3.5 ± 2.9 | 24.7 ± 15.9 | 39.4 ± 21.7 | <0.002 | 0.085 |
| Clinical disease activity index | 3.4 ± 2.5 | 22.9 ± 13.7 | 36.9 ± 20.5 | <0.002 | 0.068 |
| C-reactive protein | 3.6 ± 5.7 | 17.6 ± 36.5 | 19.4 ± 19.5 | <0.002 | 0.959 |
| Infection rate in 28 joints (ESR) | 1.8 ± 2.0 | 5.5 ± 2.6 | 6.3 ± 2.5 | <0.002 | 0.354 |
| Infection rate in 28 joints (CRP) | 1.6 ± 1.0 | 5.2 ± 2.5 | 6.4 ± 2.5 | <0.002 | 0.099 |
| Swollen joint count | 1.0 ± 1.5 | 11.9 ± 8.8 | 12.5 ± 9.3 | <0.002 | 0.993 |
| Tender joint count | 0.9 ± 1.2 | 11.5 ± 8.5 | 12.6 ± 8.5 | <0.002 | 0.904 |
| Visual analog scale | 4.6 ± 8.6 | 21.8 ± 25.8 | 56.3 ± 37.8 | <0.002 | 0.30 |
| Patient global activity | 10.1 ± 9.2 | 23.6 ± 22.4 | 55.1 ± 37.9 | 0.0088 | 0.027 |
| Evaluator global activity | 6.5 ± 4.7 | 25.1 ± 28.5 | 42.7 ± 31.1 | 0.0056 | 0.200 |
Figure 5Clinical score fitting and scatter points (VAS and PGA).